Using Mobile Phone Short Message Service (SMS) Reminders to Enhance Appointment Attendance in DM Patients
Launched by THE UNIVERSITY OF HONG KONG · Feb 14, 2017
Trial Information
Current as of April 24, 2025
Unknown status
Keywords
ClinConnect Summary
The main objective of this study is to evaluate the appointment attendance rate using SMS reminder of nurses and allied health appointments for diabetic patients, when compared to conventional telephone reminder and no reminder. We also aim at determine the factors associated with appointment attendance. Finally, we will also survey patients' acceptance and satisfaction to the SMS service.
This is a single blind randomization study. It will be carried out in Ha Kwai Chung General Outpatient Clinic.
The primary outcome of this study is to evaluate the attendance rate of each individual doc...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • With diagnosis of type 2 diabetes
- * Have more than 1 clinic services appointment under RAMP-DM programme:
- • (e.g. blood taking, diabetic nurse individual counselling, group education, diabetic complication screening, retinal photo assessment, dietician counselling, etc)
- Exclusion Criteria:
- • 1. Cannot read or receive appointment schedule on mobile phone
- • 2. Do not speak Cantonese/English or read Chinese/English
- • 3. Mentally incapacitated
- • 4. Pregnant Women
Trial Officials
Man Chi Dao, M.B.B.S.
Principal Investigator
Resident
About The University Of Hong Kong
The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kwai Chung, , Hong Kong
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials